Randomized Controlled Trial
Copyright ©The Author(s) 2017.
World J Gastrointest Endosc. Jun 16, 2017; 9(6): 273-281
Published online Jun 16, 2017. doi: 10.4253/wjge.v9.i6.273
Table 2 Pathologic diagnosis in both bright narrow band imaging and high definition white light endoscopy n (%)
bNBI (n = 495)HD-WLE (n = 511)P value
Adenomas3413260.425
Subjects with adenomas2 (ADR)185 (37.4)201 (39.3)0.523
Adenomas per adenoma carrier11.841.620.129
Size
Subjects with 0-5 mm adenomas2149 (30.1)162 (31.2)0.583
Subjects with 6-9 mm adenomas252 (10.5)52 (10.2)0.864
Subjects with ≥ 10 mm adenomas231 (6.3)31 (6.1)0.897
Adenomas < 10 mm3062900.283
Adenomas 0-5 mm2412290.334
Adenomas 6-9 mm65610.896
Adenomas ≥ 10 mm35360.837
Location
Right-sided adenomas1571550.400
Left-sided adenomas1681590.797
Histopathology
Carcinomas350.418
Tubular3153040.343
Tubulovillious10120.689
Villious20NA
Adenomas with high grade dysplasia670.992
Hyperplastic polyps1781360.020
Hyperplastic polyps < 10 mm1761350.020
SSA/Ps1370.257
Subjects with SSA/P, n (SSA/P-detection rate in %)13 (2.6)6 (1.2)0.091
Inflammatory polyps12140.572
Indeterminate or non-significant16150.987
Not submitted for histologic examinations13310.010
Xanthoma110.961